InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by KLEMP WALTER V, Chairman & CEO. Officer active across 2 companies, notably Moleculin Biotech, Inc.. Cumulatively, 7 disclosures have been published. The latest transaction was filed on 16 December 2021 — Disposition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
25,000 shares
Common Stock
SEC:0001437749-22-015536:0·
€9m425,000 shares@ €20.0164100.0% of flow
Common Stock
SEC:0001548187-21-000079·
€9m425,000 shares@ €20.016450.0% of flow
Common Stock
SEC:0001548187-21-000079:0·
13,205 shares
Common Stock
SEC:0001437749-21-016790·
13,205 shares
Common Stock
SEC:0001437749-21-016790:0·
14,718 shares
Common Stock
SEC:0001437749-21-016394·
14,718 shares
Common Stock
SEC:0001437749-21-016394:0·
7 of 7 declarations
About KLEMP WALTER V
KLEMP WALTER V serves as CEO and President at Moleculin Biotech, Inc. and Soliton, Inc. He is responsible for the strategic and operational direction of both companies. Walter plays a key role in business development and technological innovation, contributing to the growth of Moleculin Biotech and Soliton. His expertise in the biopharmaceutical sector is essential for navigating a competitive environment.
